Interleukin-22 predicts severity and death in advanced liver cirrhosis: A prospective cohort study

BMC Medicine

Volumn 10, Issue , 2012, Pages

  Kronenberger, Bernd ^a   Rudloff, Ina ^a   Bachmann, Malte ^a   Brunner, Friederike ^a   Kapper, Lisa ^a   Filmann, Natalie ^a   Waidmann, Oliver ^a   Herrmann, Eva ^a   Pfeilschifter, Josef ^a   Zeuzem, Stefan ^a   Piiper, Albrecht ^a   Mühl, Heiko ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Alcoholic liver disease; Hepatitis; Interleukin 22; Liver cirrhosis; Liver related complications; MELD

Indexed keywords

C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 22;

ADULT; AGE; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CREATININE BLOOD LEVEL; DEATH; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HAZARD RATIO; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SCORING SYSTEM;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKINS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SERUM; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 84865962962     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-102     Document Type: Article

References (32)

1. European Association for the Study of the Liver EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010, 53:397-417. European Association for the Study of the Liver.
2. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000, 164:1814-1819.
3. Wolk K, Witte E, Witte K, Warszawska K, Sabat R. Biology of interleukin-22. Semin Immunopathol 2010, 32:17-31. 10.1007/s00281-009-0188-x, 20127093.
4. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011, 12:383-390.
5. Lafdil F, Miller AM, Ki SH, Gao B. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol 2010, 7:250-254. 10.1038/cmi.2010.5, 20305686.
6. Wolk K, Witte E, Wallace E, Döcke W, Kunz S, Asadullah K, Volk H, Sterry W, Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006, 36:1309-1323. 10.1002/eji.200535503, 16619290.
7. Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005, 129:969-984. 10.1053/j.gastro.2005.06.071, 16143135.
8. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K, Nojima Y. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 2005, 52:1037-1046. 10.1002/art.20965, 15818686.
9. Bingold TM, Ziesché E, Scheller B, Sadik CD, Franck K, Just L, Sartorius S, Wahrmann M, Wissing H, Zwissler B, Pfeilschifter J, Mühl H. Interleukin-22 detected in patients with abdominal sepsis. Shock 2010, 34:337-340. 10.1097/SHK.0b013e3181dc07b1, 20220564.
10. Missé D, Yssel H, Trabattoni D, Oblet C, Lo Caputo S, Mazzotta F, Pène J, Gonzalez J, Clerici M, Veas F. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J Immunol 2007, 178:407-415.
11. Liang SC, Nickerson-Nutter C, Pittman DD, Carrier Y, Goodwin DG, Shields KM, Lambert A, Schelling SH, Medley QG, Ma H, Collins M, Dunussi-Joannopoulos K, Fouser LA. IL-22 induces an acute-phase response. J Immunol 2010, 185:5531-5538. 10.4049/jimmunol.0904091, 20870942.
12. Ma H, Liang S, Li J, Napierata L, Brown T, Benoit S, Senices M, Gill D, Dunussi-Joannopoulos K, Collins M, Nickerson-Nutter C, Fouser LA, Young DA. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008, 118:597-607. 2200300, 18202747.
13. Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld J, Matthys P. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 2009, 60:390-395. 10.1002/art.24220, 19180498.
14. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008, 14:282-289. 10.1038/nm1720, 18264109.
15. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008, 14:275-281. 10.1038/nm1710, 2901867, 18264110.
16. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008, 118:534-544. 2157567, 18172556.
17. Ziesché E, Bachmann M, Kleinert H, Pfeilschifter J, Mühl H. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem 2007, 282:16006-16015. 10.1074/jbc.M611040200, 17438334.
18. Mühl H, Bachmann M, Pfeilschifter J. Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity. Cell Microbiol 2011, 13:340-348. 10.1111/j.1462-5822.2010.01559.x, 21199257.
19. Hoegl S, Bachmann M, Scheiermann P, Goren I, Hofstetter C, Pfeilschifter J, Zwissler B, Muhl H. Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. Am J Respir Cell Mol Biol 2011, 44:369-376. 10.1165/rcmb.2009-0440OC, 20463292.
20. Radaeva S, Sun R, Pan H, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004, 39:1332-1342. 10.1002/hep.20184, 15122762.
21. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007, 27:647-659. 10.1016/j.immuni.2007.07.023, 2149911, 17919941.
22. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R, Gao B. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010, 52:1291-1300. 10.1002/hep.23837, 2947578, 20842630.
23. Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao Y, Wang X, Sun B. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 2011, 54:900-909. 10.1002/hep.24486, 21674558.
24. Zhang Y, Cobleigh MA, Lian J, Huang C, Booth CJ, Bai X, Robek MD. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 2011, 141:1897-1906. 10.1053/j.gastro.2011.06.051, 3199295, 21708106.
25. Dambacher J, Beigel F, Zitzmann K, Heeg MHJ, Göke B, Diepolder HM, Auernhammer CJ, Brand S. The role of interleukin-22 in hepatitis C virus infection. Cytokine 2008, 41:209-216. 10.1016/j.cyto.2007.11.016, 18191408.
26. Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, Ki SH, Yoo SH, Dooley S, Wang F, Young HA, Gao B. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 2011, 54:252-261. 10.1002/hep.24339, 3125432, 21465510.
27. Leipe J, Schramm MA, Grunke M, Baeuerle M, Dechant C, Nigg AP, Witt MN, Vielhauer V, Reindl CS, Schulze-Koops H, Skapenko A. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2011, 70:1453-1457. 10.1136/ard.2011.152074, 21593004.
28. Córdoba J. New assessment of hepatic encephalopathy. J Hepatol 2011, 54:1030-1040. 10.1016/j.jhep.2010.11.015, 21145874.
29. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr H, Hirth S, Weigmann B, Wirtz S, Ouyang W, Neurath MF, Becker C. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009, 206:1465-1472. 10.1084/jem.20082683, 2715097, 19564350.
30. Xing W, Zou M, Liu S, Xu T, Gao J, Wang J, Xu D. Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice. Cytokine 2011, 56:174-179. 10.1016/j.cyto.2011.07.022, 21843953.
31. Ren X, Hu B, Colletti LM. IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastrointest Liver Physiol 2010, 298:74-80.
32. Lavoie TN, Stewart CM, Berg KM, Li Y, Nguyen CQ. Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters. Scand J Immunol 2011, 74:377-382. 10.1111/j.1365-3083.2011.02583.x, 3250060, 21645026.